Differential expression of genes in retinoblastoma

Clinica Chimica Acta

Volumn 412, Issue 23-24, 2011, Pages 2015-2021

  Saxena, Parul ^a   Kaur, Jasbir ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Differential expression; DNA microarray; Real time polymerase chain reaction; Retinoblastoma; Tissue microarray

Indexed keywords

ATM GENE; ATR GENE; BRCA2 GENE; CHK1 GENE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DNA MICROARRAY; DOWN REGULATION; ECHOGRAPHY; ENUCLEATION; EPIGENETICS; EXTERNAL BEAM RADIOTHERAPY; EXTRACELLULAR MATRIX; EYE DISEASE; FLUORESCENCE ANGIOGRAPHY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; MICROARRAY ANALYSIS; MOLECULAR GENETICS; MORBIDITY; MORTALITY; ONCOGENE; OPHTHALMOSCOPY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RETINOBLASTOMA; REVIEW; SIGNAL TRANSDUCTION; SLIT LAMP; TISSUE MICROARRAY; TRANSLATIONAL RESEARCH; TUMOR SUPPRESSOR GENE; UPREGULATION;

DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETINOBLASTOMA; TISSUE ARRAY ANALYSIS;

EID: 80053634609     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2010.10.009     Document Type: Review

References (45)

1. Bike S., Chen Q., Craig C.W., Khan J. Detection of low level genomic alterations by comparative genomic hybridization based on cDNA micro-arrays. Bioinformatics 2005, 21:1138-1145.
2. Yulug I.G., Gur-Dedeoglu B. Functional genomics in translational cancer research: focus on breast cancer. Brief Funct Genomic Proteomic 2008, 7:1-7.
3. Grabowski E.F., Abramson D.H. Intraocular and extraocular retinoblastoma. Hematol Oncol Clin North Am 1987, 1:721-735.
4. Mastrangelo D., De Francesco S., Di Leonardo A., Lentini L., Hadjistilianou T. Retinoblastoma epidemiology: does the evidence matter. Eur J Cancer 2007, 43:1596-1603.
5. Sahu S., Banavali S.D., Pai S.K. Retinoblastoma: problem and perspective from India. Pediatr Hematol Oncol 1998, 15:501-508.
6. Knudson A.G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971, 68:820-823.
7. Dyer M.A., Harbour J.W. Cellular events in tumorigenesis. Clinical Ocular Oncology 2006, Elsevier, London. A.D. Singh, B. Damato, A.L. Murphree, J.D. Perry (Eds.).
8. Faha B., Ewen M.E., Tsai L.H., Livingston D.M., Harlow E. Interaction between human cyclin A and adenovirus E1A- associated p107 protein. Science 1992, 255:87-90.
9. Hurdford R.K., Cobrinik D., Lee M., Dyson N. pRb and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev 1997, 11:1447-1463.
10. Aerts I., Rouik L.L., Gauthier-Villars M., Brisse H., Doz F., Desjardins L. Retinoblastoma. Orphanet J Rare Dis 2006, 1:31-41.
11. Shields C.L., Shields J.A. Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol 2006, 17:228-234.
12. Shields C.L., Shields J.A. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol 2010, 21:203-212.
13. Chintagumpala M., Chevez-Barrios P., Paysse E.A., Plon S.E., Hurwitz R. Retinoblastoma: review of current management. Oncologist 2007, 12:1237-1246.
14. Banavali S. Evidence based management for retinoblastoma. Indian J Med Paediatr Oncol 2004, 25:35-45. Suppl 2:35-45.
15. Ganguly A., Shields C.L. Differential gene expression profile of retinoblastoma compared to normal retina. Mol Vis 2010, 16:1292-1303.
16. Chakraborty S., Khare S., Dorairaj S.K., Prabhakaran V.C., Prakash D.R., Kumar A. Identification of genes associated with tumorigenesis of retinoblastoma by microarray analysis. Genomics 2007, 90:344-353.
17. Zhao J.J., Yang J., Lin J., et al. Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst 2009, 25:13-20.
18. Calin G.A., Sevignani C., Dumitru C.D., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004, 101:2999-3004.
19. Huppi K., Volfovsky N., Mackiewicz M., et al. MicroRNAs and genomic instability. Semin Cancer Biol 2007, 17:65-73.
20. Seigel G.M., Campbell L.M., Narayan M., Gonzalez-Fernandez F. Cancer stem cell characteristics in retinoblastoma. Mol Vis 2005, 11:729-737.
21. Kim M., Kim J.H., Kim J.H., et al. Differential expression of stem cell markers and vascular endothelial growth factor in human retinoblastoma tissue. Korean J Ophthalmol 2010, 24:35-39.
22. Zhong X., Li Y., Peng F., et al. Identification of tumorigenic retinal stem cell-like cells in human solid retinoblastoma. Int J Cancer 2007, 15:2125-2131.
23. Indovina P., Acquaviva A., De Falco G., et al. Downregulation and abberant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma. J Cell Physiol 2010, 223:143-150.
24. Mu G., Liu H., Zhou F., et al. Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas. Hum Pathol 2010, 41:493-502.
25. Kim J.H., Kim J.H., Cho C.S., et al. Differential roles of matrixmetalloproteinsae-9 and -2, depending on proliferation or differentiation of retinoblastoma cells. Invest Ophthalmol Vis Sci 2010, 51:1783-1788.
26. Glubrecht D.D., Kim J.H., Russell L., et al. Differential CRX and OTX2 expression in human retina and retinoblastoma. J Neurochem 2009, 111:250-263.
27. Dalgard C.L., Gonzalez M., de Niro J.E., et al. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells. Invest Ophthalmol Vis Sci 2009, 50:4542-4551.
28. Divan A., Lawry J., Dunsmore I.R., et al. p53 and p21waf-1 expression correlates with apoptosis and cell survival in poorly differentiated, but not well-differentiated retinoblastomas. Cancer Res 2001, 61:3157-3163.
29. Bellan C., De Falco G., Tosi G.M., et al. Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation. Invest Ophthalmol Vis Sci 2002, 43:3602-3608.
30. Wilson M.W., Fraga C.H., Fuller C.E., et al. Immunohistochemical detection of multidrug-resistant protein expression in retinoblastoma treated by primary enucleation. Invest Ophthalmol Vis Sci 2006, 47:1269-1273.
31. Rhodes D.R., Yu J., Shanker K., et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 2004, 101:9309-9314.
32. Choi H., Shen R., Chinnaiyan A.M., et al. A latent variable approach for meta-analysis of gene expression data from multiple microarray experiments. BMC Bioinform 2007, 8:364-373.
33. Sherlock G., Hernandez-Boussard T., Kasarskis A., et al. The Stanford microarray database. Nucleic Acids Res 2001, 29:152-155.
34. Barrett T., Suzek T.O., Troup D.B., et al. NCBI GEO: mining millions of expression profiles-database and tools. Nucleic Acids Res 2005, 33:562-566.
35. Rhodes D.R., Yu J., Shanker K., et al. Oncomine: a cancer microarray database and integrated data-mining platform. Neoplasia 2004, 6:1-6.
36. Schneider J., Ruschhaupt M., Buness A., et al. Identification and meta-analysis of a small gene expression signature for the diagnosis of estrogen receptor status in invasive ductal breast cancer. Int J Cancer 2006, 119:2974-2979.
37. Bernard P.S., Wittwer C.T. Real-time PCR technology for cancer diagnostics. Clin Chem 2002, 48:1178-1185.
38. Peters I.R., Helps C.R., Hall E.J., et al. Real-time RT-PCR: considerations for efficient and sensitive assay design. J Immunol Methods 2004, 286:203-217.
39. Canales R.D., Luo Y., Willey J.C., et al. Evaluation of DNA microarray results with quantitative gene expression platforms. Nat Biotechnol 2006, 24:1123-1131.
40. Specht K., Richter T., Muller U., et al. Quantitative gene expression analysis in microdissected archival tissue by real-time RT-PCR. J Mol Med 2000, 78:B27.
41. Sorlie T., Wang Y., Xiao C., et al. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics 2006, 7:127-141.
42. Ma X.J., Patel R., Wang X., et al. Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay. Arch Pathol Lab Med 2006, 130:465-473.
43. Paik S., Shak S., Tang G., et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004, 351:2817-2826.
44. Jawhar N.M. Tissue microarray: a rapidly evolving diagnostic and research tool. Ann Saudi Med 2009, 29:123-127.
45. Herman J.G., Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003, 349:2042-2054.